HighTower Advisors’s Precigen PGEN Stock Holding History

HighTower Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100,000	Closed	-$15K	–	3336
2022 Q2	$15K	Buy	100,000 +99,000	+9,900%	+$147K	﹤0.01%	3033
2022 Q1	$11K	Buy	+1,000	New	+$2.44K	﹤0.01%	3209
2021 Q3	–	Sell	-100,000	Closed	-$110K	–	3370
2021 Q2	$110K	Buy	+100,000	New	+$699K	﹤0.01%	2797
2014 Q2	–	Sell	-10,463	Closed	-$1K	–	1688
2014 Q1	$1K	Buy	+10,463	New	+$290K	﹤0.01%	1579

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

HighTower Advisors's PGEN Position: Q1 2026 in Review

HighTower Advisors increased its Precigen (PGEN) stake by 9.2% in Q1 2026, buying an estimated $39.4K and bringing the position to 114,152 shares worth $442K. The position accounts for ﹤0.01% of the portfolio, ranked #2827.

HighTower Advisors first reported a position in PGEN in Q1 2014 and has held it in 46 quarters since. The position peaked at $3.94M in Q3 2018. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

HighTower Advisors held 114,152 shares of Precigen worth $442K as of Q1 2026.
HighTower Advisors bought 9,592 Precigen shares in Q1 2026, an estimated $39.4K.
Precigen made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #2827 holding.
HighTower Advisors first reported a position in Precigen in Q1 2014 and has held it in 46 quarters since.
HighTower Advisors's Precigen position peaked at $3.94M in Q3 2018.
205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.